Tramadol Extended-Release Tablets in Moderate to Moderately Severe Chronic Pain in AdultsProfile Report

被引：0
作者：
Philip I. Hair
Monique P. Curran
Susan J. Keam
机构：
[1] Wolters Kluwer Health | Adis,
来源：
CNS Drugs | 2007年 / 21卷
关键词：
Chronic Pain; Tramadol; Severe Chronic Pain; Inhibit Monoamine Reuptake; Serotonin Transport Inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：259 / 263
页数：4
相关论文
共 50 条
[31]   Steady-state pharmacokinetic comparison of a new, extended-release, once-daily morphine formulation, Avinza™, and a twice-daily controlled-release morphine formulation in patients with chronic moderate-to-severe pain [J].
Portenoy, RK ;
Sciberras, A ;
Eliot, L ;
Loewen, G ;
Butler, J ;
Devane, J .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2002, 23 (04) :292-300
[32]   Consensus statement on the use of acetaminophen/tramadol in Patients With moderate-severe pain [J].
Samper Bernal, D. ;
Alvarado Bonilla, A. ;
Canovas, L. ;
Carregal, A. ;
Fernandez Sanchez, S. P. ;
Gonzalez Mesa, J. M. ;
Guillen Astete, C. ;
Loscos Lopez, A. ;
Lozano Martinez, A. J. ;
Perez-Castejon, J. M. ;
Romero-Culleres, G. ;
Salido de Andres, E. .
MEDICINA DE FAMILIA-SEMERGEN, 2019, 45 (01) :52-62
[33]   Safety and Tolerability of Once-Daily OROS® Hydromorphone Extended-Release in Opioid-Tolerant Adults With Moderate-to-Severe Chronic Cancer and Noncancer Pain: Pooled Analysis of 11 Clinical Studies [J].
Nalamachu, Srinivas R. ;
Kutch, Michael ;
Hale, Martin E. .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2012, 44 (06) :852-865
[34]   Extended-Release, Once-Daily Morphine (Avinza) for the Treatment of Chronic Nonmalignant Pain: Effect on Pain, Depressive Symptoms, and Cognition [J].
Panjabi, Sumeet S. ;
Panjabi, Ravi S. ;
Shepherd, Marvin D. ;
Lawson, Kenneth A. ;
Johnsrud, Michael ;
Barner, Jamie .
PAIN MEDICINE, 2008, 9 (08) :985-993
[35]   Developments in managing severe chronic pain: role of oxycodone-naloxone extended release [J].
Fanelli, Guido ;
Fanelli, Andrea .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 :3811-3816
[36]   Comparative pharmacokinetics between two tablets of tramadol 37.5 mg/acetaminophen 325 mg and one tablet of tramadol 75 mg/acetaminophen 650 mg for extended-release fixed-dose combination [J].
Kim, Hyun Chul ;
Yoon, Deok Yong ;
Lee, SeungHwan ;
Jang, In-Jin ;
Hong, Jang Hee ;
Kim, JaeWoo .
TRANSLATIONAL AND CLINICAL PHARMACOLOGY, 2022, 30 (02) :112-119
[37]   Sustained Safety and Efficacy of Once-Daily Hydromorphone Extended-Release (OROS® hydromorphone ER) Compared with Twice-Daily Oxycodone Controlled-Release Over 52 Weeks in Patients with Moderate to Severe Chronic Noncancer Pain [J].
Richarz, Ute ;
Waechter, Sandra ;
Sabatowski, Rainer ;
Szczepanski, Leszek ;
Binsfeld, Heinrich .
PAIN PRACTICE, 2013, 13 (01) :30-40
[38]   Single-Entity Hydrocodone Extended-Release Capsules in Opioid-Tolerant Subjects with Moderate-to-Severe Chronic Low Back Pain: A Randomized Double-Blind, Placebo-Controlled Study [J].
Rauck, Richard L. ;
Nalamachu, Srinivas ;
Wild, James E. ;
Walker, George S. ;
Robinson, Cynthia Y. ;
Davis, Charles S. ;
Farr, Stephen J. .
PAIN MEDICINE, 2014, 15 (06) :975-985
[39]   Primary Care Considerations of the Pharmacokinetics and Clinical Use of Extended-Release Opioids in Treating Patients With Chronic Noncancer Pain [J].
Nicholson, Bruce .
POSTGRADUATE MEDICINE, 2013, 125 (01) :115-127
[40]   Safety and Tolerability of Tapentadol Extended Release in Moderate to Severe Chronic Osteoarthritis or Low Back Pain Management: Pooled Analysis of Randomized Controlled Trials [J].
Mila Etropolski ;
Brigitte Kuperwasser ;
Maren Flügel ;
Thomas Häufel ;
Bernd Lange ;
Christine Rauschkolb ;
Frank Laschewski .
Advances in Therapy, 2014, 31 :604-620
12345